Biological effects and cytotoxicity of tricalcium phosphate and formaldehyde cross-linked gelatin composite

Materials Chemistry and Physics

Volumn 45, Issue 1, 1996, Pages 6-14

  Yao, Chun Hsu ^a   Sun, Jui Sheng ^b   Lin, Feng Huei ^c   Liao, Chun Jen ^d   Huang, Chin Wang ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TATUNG INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Bioabsorbed bone graft; Cross linked gelatin; Cytotoxicity; Myoblast; Tricalcium phosphate

Indexed keywords

EID: 0002901907     PISSN: 02540584     EISSN: None     Source Type: Journal    
DOI: 10.1016/0254-0584(96)80040-X     Document Type: Article

References (30)

1. M.R. Urist, Bone Grafts, Derivatives and Substitutes, CRC Press, Boca Raton, Florida, 1994.
2. R.W. Bucholz, A. Carlton and R.E. Holmes, Hydroxyapatite and tricalcium phosphate bone graft substitutes, Orthop. Clin. North Am., 18 (1987) 323.
3. S.L. Turek, Orthopedics Principles and their Application, 4th edn., 1984, pp. 31-100.
4. C.F. Lord, M.C. Gebhardt, W.W. Tomford and H.J. Mankin, Infection in bone allografts, J. Bone Jt. Surg., 70A (1988) 369-376.
5. B.H. Berry, C.F. Lord, M.C. Gebhardt and H.J. Mankin, Allograft fractures: frequency, treatment, and end results, J. Bone Jt. Surg., 72A (1989) 825-833.
6. M. Aebi, Bone Transplantation, Updating One Osteochondral Auto and Allografting, Springer, Berlin, 1987.
7. F.H. Lin, C.C. Liu, Y.Y. Huang, C.Y. Wang and C.M. Lu, Sintered porous DP-bioactive glass and hydroxyapatite as bone substitute, J. Biomater., 15 (1994) 1087-1097.
8. J.W. Harrison, Osteosarcoma associated with metallic implant, Clin. Orthop. Relat. Res., 116 (1976) 253-260.
9. R. Holmes, R. Bucholz and V. Mooney, Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects, a histometric study, J. Bone Jt. Surg., 68A (1986) 904.
10. 5 system, J. Biomed. Eng., 13 (1991) 328-334.
11. J.F. Piecuch, A.J. Goldberg, C.V. Shastry and R.B. Chrzanowski, Compressive strength of implanted porous replamine form hydroxyapatite, J. Biomed. Mater. Res., 18 (1984) 39-45.
12. N. Blumenthal, T. Sabe and E. Barrington, Healing responses to grafting of combined collagen-decalcified bone in periodontal defects in dogs, J. Periodontol., 57 (1986) 84-88.
13. M. Minabe, A. Sugaya, H. Satou, T. Tamura, Y. Ogawa, T. Hari and Y. Watanbe, Histological study of the hydroxyapatite-collagen complex implants in periodontal osseous defects in dogs, J. Periodontol., 59 (1988) 671-678.
14. K. Ono, T. Yammamuro, T. Nakamura, Y. Kakutani and T. Kokubo, Apatite-wollastonite containing glass ceramic-fibrin mixtures as a bone defect filler, J. Biomed. Mater. Res., 22 (1988) 869-885.
15. C.C.P.M. Verheyen, J.R. de Wijin, C.A. van Blitterswijk, K. de Groot and P.M. Rozing, Hydroxyapatite/poly (L-lactide) composites: an animal study on push-out strengths and interface histology, J. Biomed. Mater. Res., 27 (1993) 433-444.
16. K.S. Tenhuisen and P.W. Brown, The formation of hydroxyapatite-gelatin composite at 38°C, J. Biomed. Mater. Res., 28 (1994) 27-33.
17. J.O. Hollinger and G.C. Battistone, Biodegradable bone repair materials, Clin. Orthop. Relat. Res., 207 (1986) 290-305.
18. D.F. Williams, Biocompatibility of Clinical Implant Materials, Vol. 2, 9 (1981) 209-234.
19. H.E. Koehlein and G. Lemperle, Studies of gelatin-resorcin-formaldehyde glue, Surgery, 66 (1969) 377-383.
20. D.P. Speer, M. Chvapil, C.D. Eskelson and J. Ulreich, Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials, J. Biomed. Mater. Res., 14 (1980) 753-764.
21. W.C. McMaster, J. Kouzelos, S. Liddls and T.R. Waugh, Tendon grafting with glutaraldehyde fixed material, J. Biomed. Mater. Res., 10 (1976) 259-271.
22. M. Vert, P. Christel, F. Chabot and J. Leary, Bioresorbable plastic materials for bone surgery, in Macromolecular Biomaterials, CRC Press, Boca Raton, Florida, 1984.
23. S.F. Konieczny, J. McKay and J.R. Coleman, Isolation and characterization of terminally differentiation chicken and rat skeletal muscle myoblasts, Dev. Biol., 91 (1982) 11-26.
24. C. Derker, R. Greggs, K. Duggan, J. Stubbs and A. Horwitz, Adhesive multiplicity in the interaction of embryonic fibrolasts and myoblasts with extracellular matrices, Cell Biol., 99 (1984) 1398-1404.
25. +2-dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis, Exp. Cell. Res., 188 (1990) 175-184.
26. T. Endo and B. Nadal-Ginard, Three types of muscle-specific gene expression in fusion-blocked rat skeleton muscle cells: translation control in EGTA-treated cells, Cell, 49 (1987) 515-528.
27. C.H. Yao, Y.L. Chang and F.H. Lin, Preparation and evaluation of B-TCP powder and cross-linked gelatin composite as bone substitute, Chinese Med. Bio. Eng., 14 (1) (1994) 47-51.
28. H.U. Blau and C.J. Epstein, Manipulation of myogenesis in vitro: reversible inhibition by DMSO, Cell, 17 (1979) 95-108.
29. C. Richler and D. Yaffe, The in-vitro cultivation and differentiation capacities of myogenic cell, Dev. Biol., 23 (1970) 1-22.
30. S.J. Raufman, C.M. Parks, J. Bohr and L.E. Faiman, Transformation is an alternative to normal skeleton muscle development, Exp. Cell Res., 125 (1980) 333-349.